|
US3311628A
(en)
*
|
1965-03-09 |
1967-03-28 |
Bristol Myers Co |
Derivatives of pyrrolo [2, 3-d] pyrimidine
|
|
CH592668A5
(pm)
*
|
1973-10-02 |
1977-10-31 |
Delalande Sa |
|
|
ES2109796T3
(es)
*
|
1994-05-03 |
1998-01-16 |
Ciba Geigy Ag |
Derivados de pirrolopirimidilo con efecto antiproliferante.
|
|
IL139787A0
(en)
*
|
1998-06-02 |
2002-02-10 |
Osi Pharm Inc |
PYRROLO [2, 3d] PYRIMIDINE COMPOSITIONS AND THEIR USE
|
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
WO1999065908A1
(en)
|
1998-06-19 |
1999-12-23 |
Pfizer Products Inc. |
PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
PT1235830E
(pt)
|
1999-12-10 |
2004-04-30 |
Pfizer Prod Inc |
Compostos de pirrolo¬2,3-d|pirimidina como inibidores das proteina cinases
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
DE10148883A1
(de)
*
|
2001-10-04 |
2003-04-10 |
Merck Patent Gmbh |
Pyrimidinderivate
|
|
EP2050751A1
(en)
|
2001-11-30 |
2009-04-22 |
OSI Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 and A3 receptors and uses thereof
|
|
US20030229067A1
(en)
|
2001-12-20 |
2003-12-11 |
Arlindo Castelhano |
Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
|
|
CN1620294A
(zh)
|
2001-12-20 |
2005-05-25 |
Osi药物公司 |
嘧啶a2b选择性拮抗剂化合物,它们的合成及用途
|
|
AU2003276591A1
(en)
|
2002-11-26 |
2004-06-18 |
Pfizer Products Inc. |
Method of treatment of transplant rejection
|
|
EP1979353A2
(en)
*
|
2006-01-19 |
2008-10-15 |
OSI Pharmaceuticals, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
RU2493157C2
(ru)
|
2008-08-20 |
2013-09-20 |
Пфайзер Инк. |
ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА
|
|
NL2022471B1
(en)
|
2019-01-29 |
2020-08-18 |
Vationpharma B V |
Solid state forms of oclacitinib
|